Page
%P
![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Article
Mixed results for heart failure therapies
Combined inhibition of angiotensin receptor and neprilysin reduces mortality from chronic heart failure over the current gold-standard angiotensin-converting-enzyme inhibitors. However, spironolactone treatmen...
-
Article
Should elderly heart failure patients be treated with β-blockade therapy?